Death · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in death compared with aspirin (low certainty).
1 finding from 1 review
Death · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in death compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
Death · survivors of stroke due to intracerebral haemorrhage
It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes death compared with avoiding anticoagulation (very low certainty).
1 finding from 1 review
Death · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in death compared with avoiding anticoagulation (moderate certainty).
1 finding from 1 review
Serious adverse events/death · rehabilitation vs less time spent
Summary of findings table ‐ More time showed no clear difference in serious adverse events/death compared with less time (low certainty).
1 finding from 1 review
Serious adverse events/death: medium‐term outcomes · rehabilitation (medium‐term outcomes)
It is very uncertain whether summary of findings table ‐ More time changes serious adverse events/death: medium‐term outcomes compared with less time (very low certainty).
1 finding from 1 review
Serious adverse events/death: long‐term outcomes ‐ not reported · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
Summary of findings table ‐ Platelet transfusion showed no clear difference in death from any cause compared with open control (moderate certainty).
1 finding from 1 review
Death during study period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant showed no clear difference in death from all causes during treatment period compared with control (low certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death from any cause compared with placebo/open control (high certainty).
1 finding from 1 review
Death at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression leads to lower death at 6 to 12 months compared with medical treatment alone (high certainty).
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
Summary of findings table ‐ Platelet transfusion probably leads to higher death or dependence (mRS 4–6) compared with open control (moderate certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes death from any cause compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death from any cause compared with placebo/open control (moderate certainty).
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (high certainty).
1 finding from 1 review
Death or severe disability (mRS > 4) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression leads to lower death or severe disability (mRS > 4) at 6 to 12 months compared with medical treatment alone (high certainty).
1 finding from 1 review
Death or moderate disability (mRS > 3) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression probably leads to lower death or moderate disability (mRS > 3) at 6 to 12 months compared with medical treatment alone (moderate certainty).
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (low certainty).
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes death or dependence (mRS 4–6) compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
Adverse events (including pain, falls and all‐cause deaths) · People performing gait rehabilitation after stroke
1 finding from 1 review